The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the O-GlcNAcylation of proteins is diminished in brain extracts from AD patients who have perturbed glucose metabolism (26,27).”
From Mitochondrial ATP synthase activity is impaired by suppressed O-GlcNAcylation in Alzheimer's disease (2015) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Research works printed but not linked: 31
- Butkinaree, 2010, O-linked beta-N-acetylglucosamine (O-GlcNAc): extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress, Biochim. Biophys. Acta, 1800, 96, 10.1016/j.bbagen.2009.07.018 · DOI · Paper page
- Chalkley, 2003, Identification of novel sites of O-N-acetylglucosamine modification of serum response factor using quadrupole time-of-flight mass spectrometry, Mol. Cell. Proteomics, 2, 182, 10.1074/mcp.M300027-MCP200 · DOI
- De Strooper, 2005, Nicastrin: gatekeeper of the gamma-secretase complex, Cell, 122, 318, 10.1016/j.cell.2005.07.021 · DOI
- Farmery, 2003, Partial purification and characterization of gamma-secretase from post-mortem human brain, J. Biol. Chem, 278, 24277, 10.1074/jbc.M211992200 · DOI
- Griffith, 1995, Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine, J. Neurosci. Res, 41, 270, 10.1002/jnr.490410214 · DOI
- Hong, 2010, FK506 reduces amyloid plaque burden and induces MMP-9 in AbetaPP/PS1 double transgenic mice, J. Alzheimers Dis, 22, 97, 10.3233/JAD-2010-100261 · DOI
- Iwatsubo, 2004, The gamma-secretase complex: machinery for intramembrane proteolysis, Curr. Opin. Neurobiol, 14, 379, 10.1016/j.conb.2004.05.010 · DOI · Paper page
- Jacobsen, 2011, O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-beta precursor protein (APP), Biochem. Biophys. Res. Commun, 404, 882, 10.1016/j.bbrc.2010.12.080 · DOI
- Jankowsky, 2001, Co-expression of multiple transgenes in mouse CNS: a comparison of strategies, Biomol. Eng, 17, 157, 10.1016/S1389-0344(01)00067-3 · DOI · Paper page
- Jin, 2007, DNA damage-inducing agent-elicited gamma-secretase activity is dependent on Bax/Bcl-2 pathway but not on caspase cascades, Cell Death Differ, 14, 189, 10.1038/sj.cdd.4402003 · DOI
- Karlström, 2002, A sensitive and quantitative assay for measuring cleavage of presenilin substrates, J. Biol. Chem, 277, 6763, 10.1074/jbc.C100649200 · DOI
- Kim, 2003, Regulated hyperaccumulation of presenilin-1 and the “gamma-secretase” complex, J. Biol. Chem, 278, 33992, 10.1074/jbc.M305834200 · DOI
- Kimura, 2009, Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model, Neurobiol. Dis, 33, 229, 10.1016/j.nbd.2008.10.006 · DOI · Paper page
- Kochi, 1999, Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells, Eur. J. Pharmacol, 372, 287, 10.1016/S0014-2999(99)00247-2 · doi:10.1016/s0014-2999(99)00247-2
- Kreppel, 1997, Dynamic glycosylation of nuclear and cytosolic proteins, J. Biol. Chem, 272, 9308, 10.1074/jbc.272.14.9308 · DOI · Paper page
- Lalonde, 2002, The neurobiological basis of spontaneous alternation, Neurosci. Biobehav. Rev, 26, 91, 10.1016/S0149-7634(01)00041-0 · DOI · Paper page
- Lester-Coll, 2006, Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease, J. Alzheimers Dis, 9, 13, 10.3233/JAD-2006-9102 · DOI · Paper page
- Liu, 2008, Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease, FEBS Lett, 582, 359, 10.1016/j.febslet.2007.12.035 · DOI · Paper page
- Macauley, 2010, Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes, Chem. Biol, 17, 937, 10.1016/j.chembiol.2010.07.006 · DOI
- Macauley, 2010, Elevation of Global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis, Chem. Biol, 17, 949, 10.1016/j.chembiol.2010.07.005 · DOI
- Macauley, 2005, O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors, J. Biol. Chem, 280, 25313, 10.1074/jbc.M413819200 · DOI · Paper page
- McGeer, 1989, Cortical glutaminase, beta-glucuronidase and glucose utilization in Alzheimer's disease, Can. J. Neurol. Sci, 16, 511, 10.1017/S0317167100029851 · DOI
- Moon, 2011, Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-beta1-42 oligomer-injected mice, J. Alzheimers Dis, 23, 147, 10.3233/JAD-2010-101263 · DOI
- Morais, 2003, The transmembrane domain region of nicastrin mediates direct interactions with APH-1 and the gamma-secretase complex, J. Biol. Chem, 278, 43284, 10.1074/jbc.M305685200 · DOI
- Robertson, 2003, Characterization of plasma inhibin forms in fertile and infertile men, Hum. Reprod, 18, 1047, 10.1093/humrep/deg225 · doi:10.1093/humrep/deg225
- Shah, 2005, Nicastrin functions as a gamma-secretase-substrate receptor, Cell, 122, 435, 10.1016/j.cell.2005.05.022 · DOI · Paper page
- Tallent, 2009, In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation, J. Biol. Chem, 284, 174, 10.1074/jbc.M807431200 · DOI
- Vosseller, 2002, Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes, Proc. Natl. Acad. Sci. U. S. A., 99, 5313, 10.1073/pnas.072072399 · DOI · Paper page
- Wells, 2001, Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc, Science, 291, 2376, 10.1126/science.1058714 · DOI · Paper page
- Yang, 2006, Thermal and UV shape shifting of surface topography, J. Am. Chem. Soc, 128, 1074, 10.1021/ja056866s · DOI
- Yuzwa, 2008, A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo, Nat. Chem. Biol, 4, 483, 10.1038/nchembio.96 · DOI · Paper page
Cited by
Glucose transporters in brain in health and disease
Koepsell, H. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02441-x · Cited by 558
Glycosylation: mechanisms, biological functions and clinical implications
He, M., Zhou, X., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01886-1 · Cited by 499
Role of O-linked N-acetylglucosamine protein modification in cellular (patho)physiology
Chatham, J. C., Zhang, J., & Wende, A. R. (2021) · Physiological Reviews · doi:10.1152/physrev.00043.2019 · Cited by 352
The role of protein glycosylation in Alzheimer disease
Schedin‐Weiss, S., Winblad, B., & Tjernberg, L. O. (2014) · The FEBS Journal · doi:10.1111/febs.12590 · Cited by 317
The Emerging Link between O-GlcNAc and Alzheimer Disease
Zhu, Y., Shan, X., Yuzwa, S. A., & Vocadlo, D. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.601351 · Cited by 267
Metadata
- Authors
- Kim, C., Nam, D. W., Park, S. Y., Song, H., Hong, H. S., Boo, J. H., Jung, E. S., Kim, Y., Baek, J. Y., Kim, K. S., Cho, J. W., & Mook-Jung, I.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 34
- Issue
- 1
- Pages
- 275-285
- ISSN
- 0197-4580
- Cited by
- 121
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- National Research Foundation of Korea
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2012.03.001
- The paper
- Kim, C., Nam, D. W., Park, S. Y., Song, H., Hong, H. S., Boo, J. H., Jung, E. S., Kim, Y., Baek, J. Y., Kim, K. S., Cho, J. W., & Mook-Jung, I. (2013). O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2012.03.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.